Neuropsychological assessment
Othera consultation to assess cognitive and psycho-behavioral functions with questionnaires
NCT Number: NCT05916625
The research aim to study in detail the motor, cognitive and affective modifications of Parkinsonian patients (compared to control subjects) at a moderate stage of the disease and to analyze by positron emission tomography (PET) imaging with the specific radioligand [11C]SB207145 the expression levels of this 5-HT4 receptor. At the same time, the study will monitor the impact of the 5-HTTLPR polymorphisms of Serotonin Transporter (SERT) and Brain-derived neurotrophic factor (BDNF) Val66Met on the expression of the 5-HT4 receptor in subjects.
Looking for future studies?
Notify Me50 year–85 year
All sexes
Interventional
Not applicable
CERMEP, Bron, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a consultation to assess cognitive and psycho-behavioral functions with questionnaires
10 mL intravenous whole blood collection in EDTA tube
Pet scan with the specific radioligand [11C]SB207145 and MRI
Time frame: During MRI procedure
difference in the tracer [11C]SB207145 's binding, the specific binding of the tracer will be calculated for each voxel with respect to a reference zone (the white matter of the cerebellum).
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and the clinical scores on the motor questionnaires
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and the clinical scores on the non-motor questionnaires
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and the clinical scores on the cognitive questionnaires
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and the clinical scores on the psychobehavioral questionnaires
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and SERT polymorphism data (5-HTTLPR polymorphism, evaluated as presence/absence)
Time frame: During MRI procedure
Relationship between the level of expression of the tracer and BDNF polymorphism data (Val66Met rs6265 polymorphism, evaluated as presence/absence)
Hospices Civils de Lyon
Other
Exploratory Study of the Expression of the Serotonergic 5-HT4 Receptor in Parkinson's
Acronym: PARK 5-HT4
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06133283
Basal Ganglia Diseases, Brain Diseases
San Antonio, Texas, United States
View Trial DetailsNCT05766813
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07723027
Basal Ganglia Diseases, Brain Diseases
Shakargarh, Punjab Province, Pakistan
View Trial DetailsNCT07361250
Basal Ganglia Diseases, Brain Diseases
Wuhan, Hubei, China
View Trial Details